| Serial Number | 99245099 |
| Word Mark | SYNT |
| Filing Date | Friday, June 20, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, February 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 3, 2026 |
| Goods and Services | Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders, namely, Alzheimer's Disease, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Pharmaceutical preparations for the treatment and prevention of chronic metabolic diseases, metabolic conditions, and functional neurological disorders; Biological preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 20, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Syntis Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02125 US |
| Event Date | Event Description |
| Friday, June 20, 2025 | NEW APPLICATION ENTERED |
| Friday, June 20, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 20, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 10, 2025 | ASSIGNED TO EXAMINER |
| Monday, November 10, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, November 10, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, November 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 9, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 9, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 9, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 10, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 25, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |